)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
SWK
SWK (SWKH) investor relations material
SWK has been acquired by Runway Growth Finance Corp
SWK EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 summary31 Mar, 2026
Opening remarks and agenda
Meeting called to order at 9:00 A.M. Central Time on March 31, 2026, conducted virtually in accordance with bylaws and Delaware law.
Attendance confirmed, minutes recorded by outside counsel, and meeting limited to formal business as described in the notice and proxy statement.
Specific resolutions to be voted on
Vote to adopt the merger agreement and plan of merger with Runway Growth Finance Corp. and related entities.
Advisory vote on compensation for named executive officers in connection with the merger.
Vote on compensation for each board member in connection with the merger.
Vote to approve adjournment of the meeting if more time is needed to solicit proxies for the merger proposal.
Discussions on mergers, acquisitions, or other significant changes
Proposal to merge with and into Runway Portfolio Corp., with Runway Portfolio Corp. surviving as a wholly owned subsidiary of Runway Portfolio Holding Corp.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from SWK
- Shift to Finance Receivables, $2.5M net loss, $4/share dividend, merger pending with Runway.SWKH
Q4 2025 - Shareholders to vote on SWK's merger with RWAY, offering cash or stock and board-recommended approval.SWKHProxy Filing
- Annual meeting to vote on directors, auditor, executive pay, and equity plan extension.SWKHProxy Filing
- Annual meeting to vote on directors, auditor, executive pay, and equity plan extension.SWKHProxy Filing
- Shareholders to vote virtually on directors, auditor, compensation, and equity plan June 13, 2025.SWKHProxy Filing
- Q2 2025 saw asset sales, a $4/share dividend, and robust loan yields drive value creation.SWKHQ2 2025
- Q3 revenue up 15%, but net income fell on higher credit losses and asset impairment.SWKHQ3 2024
- Q2 2024 revenue up 21% to $11.5M, net income $4.4M, with portfolio growth and asset impairment.SWKHQ2 2024
- Q4 net income doubled, revenue up 25%, royalty monetization and buybacks drive dividend plans.SWKHQ4 2024
SWK
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
At the Intersection of Finance and Healthcare
SWK Holdings Corporation is an American finance company that primarily operates within the healthcare sector, with a focus on life sciences and pharmaceuticals. Given the capital-intensive nature of healthcare innovations, SWK Holdings provides financial support and investments to initiatives in the sector. The company offers customized financing solutions tailored to support companies in various stages of research, development, and commercialization.
Texas Made
SWK Holdings was founded in 1996 and is headquartered in Dallas, Texas. The company operates in two different segments: Life Science Specialty Finance and Enteris BioPharma, which are both centered on SWK’s core focus on monetizing revenue streams and intellectual property within the life sciences sector. The company's approach is centered on understanding the specific needs of healthcare and biotech enterprises, offering financial structures that facilitate growth and advancement. Given the complex nature of the industry, having the right expertise and experience is absolutely paramount to achieving the best possible results. Some companies that SWK has worked closely with include Aziyo, Biolase, and Eton Pharmaceuticals.
Life Science Specialty Finance
Recognizing the unique financial challenges companies in life sciences face, particularly when it comes to drug development and medical innovation, SWK provides tailored financing solutions. These are designed to address the capital-intensive nature of research, clinical trials, and product commercialization. Through its specialty finance operations, SWK extends secured loans to smaller life science companies, bridging funding gaps and ensuring the continuity of research. In return, SWK typically benefits from interest and fees, as well as royalties from successfully commercialized products.
Enteris BioPharma
Enteris BioPharma, a subsidiary of SWK Holdings, is a biotechnology company specializing in developing innovative drug delivery solutions. One of its core technologies is the Peptelligence™ platform, which enables oral delivery of molecules that are traditionally administered through injections.